arrow
X

Xiaoqing Yan

Zhejiang Sci-Tech University
H指数:40
被引数:4,726

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study
2024-02-0139
OA